ASX
Starpharma Holdings Limited
SPL:ASX•Healthcare
Sensitive ASX Announcement
AstraZeneca presents 1st DEP candidate as Bcl2/xL inhibitor
Published: 28/09/17, 11:49am (AEST)•2 pages